Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Merrion amends IPO

Merrion (Dublin, Ireland) lowered the proposed price range of its IPO

Read the full 112 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE